Data / Drug companies / Cytochrome P450 3A Inhibitor
Cytochrome P450 3A Inhibitor drugs: 6 drugs from 15 companies in the FDA NDC directory
Cytochrome P450 3A Inhibitor is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 28 products in this class from 15 companies, covering 6 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on February 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 15Companies
- 28Products
- 6Drugs by generic name
Drugs in the Cytochrome P450 3A Inhibitor class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Ritonavir | 9 | 8 |
| Lopinavir and ritonavir | 9 | 4 |
| Darunavir ethanolate and cobicistat | 4 | 2 |
| Atazanavir and cobicistat | 1 | 1 |
| Cobicistat | 1 | 1 |
| Ritonavir 100 mg | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| AbbVie Inc. | 5 | tablet, film coated; solution | New drug applications (NDA) | August 16, 2022 |
| Janssen Products, LP | 4 | tablet, film coated; tablet, for suspension | New drug applications (NDA) | February 27, 2026 |
| Camber Pharmaceuticals, Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | June 7, 2021 |
| Gilead Sciences, Inc. | 3 | tablet, film coated; tablet | New drug applications (NDA) | November 5, 2015 |
| Laurus Labs Limited | 2 | tablet, film coated | Generic drugs (ANDA) | March 22, 2022 |
| Macleods Pharmaceuticals Limited | 2 | tablet, film coated | Generic drugs (ANDA) | July 25, 2024 |
| A-S Medication Solutions | 1 | tablet, film coated | New drug applications (NDA) | January 31, 2015 |
| American Health Packaging | 1 | tablet, film coated | Generic drugs (ANDA) | December 27, 2018 |
| Amneal Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | September 21, 2018 |
| Aurobindo Pharma Limited | 1 | tablet, film coated | Generic drugs (ANDA) | September 17, 2018 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | September 17, 2018 |
| Bryant Ranch Prepack | 1 | tablet, film coated | Generic drugs (ANDA) | September 17, 2018 |
| Cipla USA Inc. | 1 | tablet | Generic drugs (ANDA) | March 23, 2022 |
| E.r. Squibb & Sons, L.L.C. | 1 | tablet | New drug applications (NDA) | January 29, 2015 |
| NuCare Pharmaceuticals,Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | September 17, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 19 | 67.9% |
| Tablet | 6 | 21.4% |
| Solution | 1 | 3.6% |
| Tablet, for suspension | 1 | 3.6% |
| Powder | 1 | 3.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.